Prostate Cancer Daily

June 11, 2026

Videos

Peer-to-Peer Clinical Conversations

Treatment Intensification in Older and Comorbid Patients with Metastatic Hormone-Sensitive Prostate Cancer - Alicia Morgans

Alicia Morgans

Alicia Morgans discusses treatment intensification in older and comorbid patients with metastatic hormone-sensitive prostate cancer.

View

PROSTest mRNA Assay Tested for Response Prediction to Lutetium PSMA in mCRPC - Mark Kidd

Mark Kidd

Mark Kidd describes PROSTest, an mRNA blood assay measuring tumor biology genes, covering its prospective multicenter evaluation in men with mCRPC undergoing lutetium-177 PSMA therapy.

View

Beyond the Abstracts

Cost-Effectiveness Analysis of 177Lu-PSMA-617 Versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer from a U.S. Health Care Perspective - Beyond the Abstract

Artificial Intelligence in Diagnostic, Prognostic, and Predictive Genomic Biomarkers for Prostate Cancer: Ready for Prime Time? - Beyond the Abstract

Conference Coverage

SNMMI 2026: The LuRa Study: Safety and Survival Outcomes of Radium-223 in Patients with mCRPC with Prior 177Lu-PSMA Radioligand Therapy

ASCO 2026: Discussant - the PROTEUS Journey: Setting a New Course for High-Risk Prostate Cancer

ASCO 2026: Perioperative (Neoadjuvant and Adjuvant) Apalutamide + ADT Versus Placebo + ADT with Radical Prostatectomy in High-Risk Localized or Locally Advanced Prostate Cancer: Final Analysis of the PROTEUS Phase 3 Study

AUA 2026: Phase 3 Study of 68Ga-PSMA-11 PET Combined with MRI for the Detection of Prostate Cancer (BIPASS)

AUA 2026: A Phase 3 Trial of the Androgen Receptor Ligand-directed Degrader BMS-986365 versus Investigator’s Choice in Patients with Metastatic Castration-resistant Prostate Cancer (CA071-1000 – rechARge)

Articles

Editor Selected Abstracts and Commentaries

Prostate Cancer

Delphi consensus on ex vivo fluorescence confocal microscopy in robot-assisted radical prostatectomy.

Real-Time Assessment of Surgical Margins During Radical Prostatectomy: A Comprehensive Review.

Proton Beam Therapy in Prostate Cancer: Clinical Evidence, Controversies and Future Directions.

The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) study.

Impact of Homologous Recombination Repair Gene Mutations on Survival in Metastatic Prostate Cancer: A Real-World Analysis from an observational database.

Epigenetic and oncogenic inhibitors converge to drive a metabolic catastrophe in castration-resistant prostate cancer.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Prostate Cancer Daily

Prostate Cancer

Login